机械通气专业护理机构中耳念珠菌定植与传播的相关因素:纽约2016-2018
本研究在纽约州6家可通气专业护理机构(vSNF)开展病例对照调查,纳入60例耳念珠菌定植者与218例对照。多因素分析显示,使用呼吸机、既往90天碳青霉烯类或氟康唑暴露、既往6个月急性住院均与定植独立相关;建议对具备上述风险因素者靶向筛查并加强抗菌药物管理。
要点
- 使用呼吸机者耳念珠菌定植风险显著升高(aOR 5.9)。
- 既往90天碳青霉烯类或氟康唑暴露与定植独立相关。
- 既往6个月急性住院史亦为定植风险因素。
核心结论
- 在vSNF居民中,使用呼吸机、既往90天碳青霉烯类或氟康唑暴露、既往6个月急性住院与耳念珠菌定植独立相关。
- 对具备上述风险因素的vSNF患者进行靶向筛查有助于发现定植者并落实感染控制措施。
- 抗菌药物管理可能是预防耳念珠菌定植的重要环节。
研究设计与样本
- 2016-2018年纽约州卫生部在vSNF开展点患病率调查,采用病例对照设计。
- 病例定义为同次调查中耳念珠菌定植居民,对照为拭子阴性居民,最多1:4匹配。
- 共纳入来自6家vSNF的60例病例和218例对照,从病历提取转院、抗菌药物使用和病史资料。
主要发现
- 使用呼吸机与定植相关(aOR 5.9;95%CI 2.3-15.4)。
- 既往90天接受碳青霉烯类抗生素与定植相关(aOR 3.5;95%CI 1.6-7.6)。
- 既往6个月至少1次急性护理医院就诊与定植相关(aOR 4.2;95%CI 1.9-9.6)。
- 既往90天接受全身性氟康唑与定植相关(aOR 6.0;95%CI 1.6-22.6)。
临床怎么用
- 对vSNF中使用呼吸机、近期碳青霉烯类或氟康唑暴露、近期急性住院的居民考虑靶向筛查耳念珠菌定植。
- 检出定植者后应实施感染控制措施以阻断传播。
- 将抗菌药物管理纳入耳念珠菌定植预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Candida auris is an emerging, multidrug-resistant yeast that spreads in healthcare settings. People colonized with C. auris can transmit this pathogen and are at risk for invasive infections. New York State (NYS) has the largest US burden (>500 colonized and infected people); many colonized individuals are mechanically ventilated or have tracheostomy, and are residents of ventilator-capable skilled nursing facilities (vSNF). We evaluated the factors associated with C. auris colonization among vSNF residents to inform prevention interventions. METHODS: During 2016-2018, the NYS Department of Health conducted point prevalence surveys (PPS) to detect C. auris colonization among residents of vSNFs. In a case-control investigation, we defined a case as C. auris colonization in a resident, and identified up to 4 residents with negative swabs during the same PPS as controls. We abstracted data from medical records on patient facility transfers, antimicrobial use, and medical history. RESULTS: We included 60 cases and 218 controls identified from 6 vSNFs. After controlling for potential confounders, the following characteristics were associated with C. auris colonization: being on a ventilator (adjusted odds ratio [aOR], 5.9; 95% confidence interval [CI], 2.3-15.4), receiving carbapenem antibiotics in the prior 90 days (aOR, 3.5; 95% CI, 1.6-7.6), having ≥1 acute care hospital visit in the prior 6 months (aOR, 4.2; 95% CI, 1.9-9.6), and receiving systemic fluconazole in the prior 90 days (aOR, 6.0; 95% CI, 1.6-22.6). CONCLUSIONS: Targeted screening of patients in vSNFs with the above risk factors for C. auris can help identify colonized patients and facilitate the implementation of infection control measures. Antimicrobial stewardship may be an important factor in the prevention of C. auris colonization.
引用
- Rossow J, Ostrowsky B, Adams E, et al. Factors Associated With Candida auris Colonization and Transmission in Skilled Nursing Facilities With Ventilator Units, New York, 2016-2018. Clin Infect Dis. 2021. PMID: 32984882. doi:10.1093/cid/ciaa1462
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。